FDA•MODERATE
Midodrine Hydrochloride Tablets, USP 5 mg
Major Pharmaceuticals is recalling Midodrine Hydrochloride Tablets 5 mg (NDC 0904-6818-06) due to inadequately sealed blister packaging.
Filters
Category
Agency
Severity
Drugs Recalls
Back to home ←
FDA•MODERATESemaglutide Compounding APIHarbin Jixianglong Biotech is recalling Semaglutide API due to failures in process and bacterial endotoxin method validation.
2 products
FDA•MODERATEAmantadine HCl Capsules 100 mgAvKARE is recalling Amantadine HCl Capsules 100 mg (NDC 50268-069-15) nationwide due to failed dissolution specifications.
FDA•LOWEptifibatide Injection 75 mg/100 mLSlate Run Pharmaceuticals recalls Eptifibatide Injection 75 mg/100 mL vials (NDC 70436-027-80, 70436-163-80) due to incorrect dosing-route labeling.
FDA•CRITICALWhite Vein Advanced Alkaloids Chewable TabletsShaman Botanicals is recalling White Vein Advanced Alkaloids Chewable Tablets due to higher-than-labeled levels of 7-hydroxymitragynine.
2 products
FDA•MODERATEAdbry (tralokinumab-ldrm) Injection 300 mg/2mLLEO Pharma is recalling Adbry injection autoinjectors (NDC 50222-350-91, 50222-350-02) due to wool fiber contamination affecting sterility.
FDA•MODERATECetrorelix Acetate for Injection Kit 0.25 mgMeitheal Pharmaceuticals recalls Cetrorelix Acetate injection kits (NDC 71288-558-90) due to missing or duplicated needles.
FDA•MODERATEThiamine HCl InjectionFagron Sterile Services is recalling Thiamine HCl 500 mg injection due to a lack of assurance of sterility.
5 products
FDA•MODERATEDexamethasone Sodium Phosphate Injection, USP 100 mg/10 mLSomerset Therapeutics is recalling Dexamethasone Sodium Phosphate Injection (NDC 70069-025-10/01) due to out-of-specification impurities at expiry.
FDA•LOWPitavastatin Tablets, 2 mgNorthstar Rx LLC is recalling Pitavastatin Tablets, 2 mg (NDC 72603-479-01) due to a foreign 1 mg tablet found in bottles.
FDA•MODERATEPro Numb Tattoo Numbing SprayPro Numb is recalling 5% Lidocaine Tattoo Numbing Spray due to cGMP manufacturing deviations.
2 products
FDA•MODERATEMetoprolol Succinate Extended-Release TabletsTeva is recalling Metoprolol Succinate Extended-Release Tablets due to failed dissolution specifications.
4 products
FDA•MODERATEDiclofenac Sodium Topical Gel 3%Taro Pharmaceuticals is recalling Diclofenac Sodium Topical Gel 3% (100 g) due to viscosity specification failure.
FDA•MODERATEAsteria Health Testosterone Sterile PelletsAsteria Health is recalling 100 mg Testosterone sterile pellets due to the potential presence of metal particulate matter.
25 products
FDA•MODERATETrazodone Hydrochloride 50 mg TabletsGranules Pharmaceuticals is recalling Trazodone Hydrochloride 50 mg tablets (NDC 70010-231-01) due to foreign tablets or capsules in bottles.
FDA•MODERATESodium Iodide (I-131) Therapeutic Oral SolutionRadnostix is recalling Sodium Iodide (I-131) Therapeutic Oral Solution due to the presence of particulate matter.
FDA•MODERATEBisoprolol Fumarate and Hydrochlorothiazide Tablets 2.5 mg/6.25 mgUnichem Pharmaceuticals recalls Bisoprolol/Hydrochlorothiazide 2.5/6.25 mg tablets (NDC 29300-187-01) due to N-Nitroso Bisoprolol impurity specification failure.
FDA•LOWDoxazosin Tablets, USP 4 mgUnichem is recalling Doxazosin Tablets 4 mg (NDC 29300-353-10) due to incorrect tablet imprinting that may cause medication errors.
FDA•MODERATEMed Nap BZK Antiseptic TowelettesAcme United is recalling Med Nap BZK Antiseptic Towelettes (NDC 0924-0246-01) due to CGMP deviations.
22 products
FDA•CRITICALUDENYCA Pegfilgrastim-cbqv InjectionUDENYCA pegfilgrastim-cbqv prefilled syringes (Lot 2199821) recalled due to improper storage temperature.
FDA•MODERATEThyroid, USPSpecialty Process Labs is recalling Thyroid, USP (NDC 81305-100-02) due to subpotency.
FDA•MODERATEMethylprednisolone Tablets USP Dosepak 4 mgGreenstone is recalling methylprednisolone 4 mg tablets (NDC 59762-4440-2) due to incorrect blister foil orientation causing incorrect dosing information.
FDA•MODERATEOxycodone Hydrochloride Tablets, USP 5 mgAmerican Health Packaging is recalling Oxycodone Hydrochloride 5 mg tablets due to defective blister card seals that allow tablets to fall out.
FDA•MODERATEIsotretinoin 40 mg CapsulesTeva is recalling Isotretinoin 40 mg capsules due to superpotency and subpotency concerns that may affect treatment efficacy or safety.
2 products
FDA•MODERATEFurosemide Tablets USP 40 mgRising Pharmaceuticals is recalling Furosemide Tablets 40 mg (NDC 64980-563-10) due to foreign substance contamination.
FDA•MODERATEAQ 120 GFEW Aquarion Preserved CartridgesEncon Safety Products is recalling AQ 120 GFEW Aquarion Preserved Cartridges due to cGMP manufacturing deviations.
FDA•MODERATELanreotide Injection 120 mg/0.5 mLCipla is recalling Lanreotide Injection 120 mg/0.5 mL (NDC 69097-870-67) due to particulate matter contamination.